Healthy Tips

If you have gout and heart disease, choosing a uric acid medicine can feel like a big decision. You want fewer flares, but you also want to protect your heart.

Allopurinol and febuxostat are both urate-lowering medicines. They lower uric acid in different ways, and both can be useful. The right choice depends on your medical history, kidney function, side effects, and cardiovascular risk.

Why heart safety comes up in gout care

People with gout often have other conditions, such as high blood pressure, kidney disease, diabetes, high cholesterol, or a history of heart problems. These conditions can overlap with high uric acid and inflammation.

That does not mean gout medicine causes heart disease. It means medication decisions should be made with the whole person in mind.

Allopurinol in plain language

Allopurinol has been used for many years and is often the first urate-lowering medicine doctors consider. It works by reducing the body’s production of uric acid.

It is usually started at a low dose and adjusted over time. People with kidney disease may need extra attention to dosing and monitoring.

Febuxostat in plain language

Febuxostat also lowers uric acid production. It may be considered when allopurinol is not tolerated or does not work well enough for a particular patient.

Some studies have raised concerns about cardiovascular outcomes in certain higher-risk patients, while other studies have shown more balanced results. This is why your personal heart history matters.

What this means for you

If your doctor is choosing between these medicines, ask about your own risk profile rather than focusing only on headlines.

• Do I have known heart disease or prior stroke?
• What is my kidney function?
• Have I ever had a serious reaction to allopurinol?
• What uric acid level are we aiming for?
• How will we monitor side effects and progress?

Lifestyle steps still matter too. Our guide to lifestyle changes and non-drug strategies for gout can support the medicine plan your clinician recommends.

Bottom line

Allopurinol and febuxostat can both lower uric acid, but heart safety deserves an honest conversation. The safest choice is the one that matches your medical history and is monitored over time. Do not take this decision arbitrary and always consult your doctor.

Resources: Cardiovascular safety trials and guideline discussions comparing allopurinol and febuxostat in gout care, including CARES, FAST, and American College of Rheumatology guidance.

Related gout reading

• Febuxostat and allopurinol heart safety
• Allopurinol and heart risk
• Urate-lowering therapy and CKD
• What changed in gout care

Resources: research comparing allopurinol and febuxostat for cardiovascular outcomes in gout treatment.